Although the number of specimens analyzed limited our study, we still observed a significant decrease in UGT1A1 mRNA levels among postmenopausal breast cancer cases versus controls and among EA women with breast cancer compared to EA without breast cancer. The gene discussed is UGT1A1; the disease is breast cancer.